Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

BMB. 2022; 7(3): 288-290


Abnormal uterine bleeding associated with bupropion: a case report

Melek Kanarya Vardar, Evrim Ebru Kovalak.




Abstract

In the literature, many cases of abnormal uterine bleeding associated with selective serotonin reuptake inhibitors as an antidepressant treatment side effect have been reported. However, abnormal uterine bleeding associated with bupropion, a norepinephrine-dopamine reuptake inhibitor, has been reported in only two case reports to date. A 28-year-old, oligomenorrheic female patient was admitted to the psychiatry department with symptoms of depression. The patient was diagnosed with major depression and bupropion 150mg/day was prescribed. After initiation of the treatment the patient experienced mild-to-moderate uterine bleeding, which resolved with discontinuation of the drug. In the patient's anamnesis, it was learned that the same side effect developed with the previous bupropion treatment. A comprehensive examination of the patient suggested that this adverse effect could strongly be associated with bupropion. This case supports the view that antidepressants can cause bleeding abnormalities, in particular vaginal bleeding caused by bupropion usage. Physicians who prescribe bupropion should carefully follow up their patients to identify such adverse effects.

Key words: Bupropion, abnormal uterine bleeding, adverse effect, case reports






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.